Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement
Description
In the development of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) drugs, its main protease (M^(pro)), which is an essential enzyme for viral replication, is a promising target. To date, the M^(pro) inhibitors, nirmatrelvir and
